Marksans Pharma (NSE:MARKSANS) Pre-Tax Income : ₹4,274 Mil (TTM As of Dec. 2023)

Marksans Pharma Pre-Tax Income Chart

Marksans Pharma Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Pre-Tax Income		Get a 7-Day Free Trial					1,043.07	1,571.72	3,021.64	2,475.11	3,376.53

Marksans Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															792.02	1,041.74	968.26	1,137.68	1,126.58

Competitive Comparison of Marksans Pharma's Pre-Tax Income

For the Drug Manufacturers - General subindustry, Marksans Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marksans Pharma's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's Pre-Tax Income falls into.

Marksans Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Marksans Pharma's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Marksans Pharma's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,274 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marksans Pharma  (NSE:MARKSANS) Pre-Tax Income Explanation

Marksans Pharma's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

During the past 13 years, Marksans Pharma's highest Pretax Margin was 22.08%. The lowest was 1.96%. And the median was 13.82%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marksans Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Marksans Pharma (NSE:MARKSANS) Business Description